Search by Drug Name or NDC

    NDC 00135-7031-01 Panadol 325; 5 mg/1; mg/1 Details

    Panadol 325; 5 mg/1; mg/1

    Panadol is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00135-7031
    Product ID 0135-7031_31ba233e-eeaf-4124-822c-87faffb98ca3
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Panadol
    Proprietary Name Suffix Cold and Flu NonDrowsy
    Non-Proprietary Name acetaminophen and phenyleprine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 325; 5
    Active Ingredient Units mg/1; mg/1
    Substance Name ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00135-7031-01 (00135703101)

    NDC Package Code 0135-7031-01
    Billing NDC 00135703101
    Package 50 PACKET in 1 CARTON (0135-7031-01) / 2 TABLET, FILM COATED in 1 PACKET
    Marketing Start Date 2022-12-20
    NDC Exclude Flag N
    Pricing Information N/A